UnitedHealth Group Inc. (UNH) Stake Held by Financial & Investment Management Group Ltd.
Financial & Investment Management Group Ltd. continued to hold its position in shares of UnitedHealth Group Inc. (NYSE:UNH) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,721 shares of the healthcare conglomerate’s stock at the end of the second quarter. Financial & Investment Management Group Ltd.’s holdings in UnitedHealth Group were worth $243,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of Montreal Can acquired a new stake in UnitedHealth Group during the second quarter worth $207,013,000. Dodge & Cox boosted its stake in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock worth $1,957,113,000 after buying an additional 1,324,136 shares during the last quarter. Prudential Financial Inc. boosted its stake in UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock worth $316,927,000 after buying an additional 790,220 shares during the last quarter. NN Investment Partners Holdings N.V. acquired a new stake in UnitedHealth Group during the first quarter worth $83,434,000. Finally, UBS Asset Management Americas Inc. boosted its stake in UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock worth $570,338,000 after buying an additional 508,995 shares during the last quarter. Institutional investors and hedge funds own 85.78% of the company’s stock.
UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% on Friday, reaching $136.66. The company had a trading volume of 2,568,703 shares. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48. The stock has a market capitalization of $130.15 billion, a PE ratio of 21.39 and a beta of 0.57. The stock has a 50 day moving average price of $137.80 and a 200 day moving average price of $136.35.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating the Zacks’ consensus estimate of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. Analysts expect that UnitedHealth Group Inc. will post $7.90 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were issued a $0.625 dividend. The ex-dividend date was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.83%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
A number of research firms have recently weighed in on UNH. Credit Suisse Group AG reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, June 10th. Leerink Swann reaffirmed an “outperform” rating and set a $165.00 price target (up previously from $155.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. FBR & Co reaffirmed an “outperform” rating and set a $155.00 price target (up previously from $145.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price target for the company in a research report on Friday, July 22nd. Finally, Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $161.00 price target (up previously from $145.00) on shares of UnitedHealth Group in a research report on Friday, July 22nd. One research analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group has a consensus rating of “Buy” and an average target price of $155.35.
In other UnitedHealth Group news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a filing with the SEC, which is available at this link. 1.65% of the stock is currently owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.